News & Updates

A defecation posture modification device (DPMD), also known as a potty stool, is both safe and beneficial for children with functional constipation (FC), helping them wean off pharmacotherapy and improving their bowel function, according to a study presented at the recently concluded 2022 Digestive Disease Week (DDW 2022).

Patients with coronary heart disease (CHD) may have an increased risk of major adverse cardiovascular (CV) events (MACE)* if they also have insomnia, suggested a study presented at the ESC Preventive Cardiology 2022 annual congress.

Among myocardial infarction (MI) patients who had undergone percutaneous coronary intervention (PCI), those with low fat-free mass and body fat seem to suffer from excess mortality risk, a recent study has found. Body composition appears to be a better mortality predictor than body mass index.

Treatment with eldecalcitol, an active vitamin D analogue, does not result in a significant reduction in diabetes incidence and has failed to improve the rate of regression to normoglycaemia relative to placebo among patients with impaired glucose tolerance at high risk for type 2 diabetes (T2D), results of a study have shown.

Patients with treatment-refractory gastroesophageal reflux disease (GERD) may find relief from antireflux mucosectomy (ARMS), suggests a study.